The FTC is preparing to block Amgen's acquisition of Horizon Therapeutics, marking a new effort by antitrust enforcers to prevent a merger of pharmaceutical companies.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...